Eledon Pharmaceuticals Inc. buy Maxi_Scalibusa
Start price
23.01.21
/
50%
€13.36
Target price
23.01.22
€100.00
Performance (%)
-77.10%
End price
24.01.22
€3.06
Summary
This prediction ended on 24.01.22 with a price of €3.06. Massive losses of -77.10% were the result for the BUY prediction by Maxi_Scalibusa. Maxi_Scalibusa has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Eledon Pharmaceuticals Inc. | 4.348% | 4.348% | -64.706% | -43.750% |
| iShares Core DAX® | 3.002% | 3.742% | 24.169% | 65.664% |
| iShares Nasdaq 100 | 2.966% | 1.308% | 9.141% | 111.170% |
| iShares Nikkei 225® | 5.606% | 4.472% | 21.237% | 55.883% |
| iShares S&P 500 | 2.312% | 1.880% | 6.333% | 67.956% |
According to Maxi_Scalibusa what are the pros and cons of Eledon Pharmaceuticals Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by Maxi_Scalibusa for this prediction
In the thread Novus Therapeutics Inc. diskutieren
In the thread Trading Novus Therapeutics Inc.
Die von Maxi_Scalibusa gewählte maximale Laufzeit wurde überschritten